SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-007528
Filing Date
2022-11-10
Accepted
2022-11-10 17:01:01
Documents
50
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q phio_i10q-093022.htm   iXBRL 10-Q 615105
2 CERTIFICATION phio_ex3101.htm EX-31.1 9369
3 CERTIFICATION phio_ex3201.htm EX-32.1 4741
  Complete submission text file 0001683168-22-007528.txt   3211128

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phio-20220930.xsd EX-101.SCH 24362
5 XBRL CALCULATION FILE phio-20220930_cal.xml EX-101.CAL 35022
6 XBRL DEFINITION FILE phio-20220930_def.xml EX-101.DEF 93870
7 XBRL LABEL FILE phio-20220930_lab.xml EX-101.LAB 212884
8 XBRL PRESENTATION FILE phio-20220930_pre.xml EX-101.PRE 173585
44 EXTRACTED XBRL INSTANCE DOCUMENT phio_i10q-093022_htm.xml XML 480926
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 221378298
SIC: 2834 Pharmaceutical Preparations